a risk-adapted prostate-specific antigen(PSA)screening using a baseline PSA value at ages 45-50 may significantly reduce the number needed to diagnose maintaining the benefits of screening.PROBASE is a randomized risk-adapted screening trial currently ongoing in Germany to answer this important ...
However, this method is not reliable for detecting prostate cancer and is not a recommended screening tool. Next Steps Based on Your Prostate Cancer Screening Results If your prostate cancer screen was negative, you may only need rescreening every two years, provided your PSA was less than 2.5...
According to a research letter published inJAMA Internal Medicine, prostate cancer screening frequently results in biopsies that find clinically insignificant cancer or no cancer at all. Ad A polygenic risk score (PRS) can measure thedisease risksassociated with genetic variants that an individual carri...
Is there a screening test for prostate cancer? Why is it important to catch it early? Currently, the main screening test for prostate cancer involves taking a blood sample and testing it for the level of a marker called prostate-specific antigen (PSA). Higher levels of PSA in the blood ca...
The most widely used screening tool for evaluating kidney function is the creatinine blood test. Most standard CBC/chemistry blood profiles include the creatinine test to evaluate kidney function. According to standard reference ranges, a creatinine blood level of up to 1.5 mg/dL is considered norma...
When a competent patient refuses a recommended medical test or procedure, the physician should make sure the patient understands the potential negative ... RF Wagner,A Torres,S Proper - 《Dermatologic Surgery》 被引量: 8发表: 2013年 Anxiety Disorders in Childhood While the child who shrieks at...
Take the case of study of screening for cancer, where the aim is to determine the relationship between results of the screening test and true disease status. Patients are screened using an imaging technology (the diagnostic test), and those with abnormal findings recommended for biopsy (the gold...
Latner, Ann W
The latest findings from a major Cancer Research UK-funded PSA trial included over 400,000 men and has backed up that a one-off PSA test doesn't save lives. Seek and you shall find No screening test is perfect and there's always a trade-off between lives saved and the harms of overdi...
Several questions and answers on non-screening Prostate-Specific Antigen (PSA) covered by medicare are presented including one on checking PSA in a patient on testosterone therapy, pre-authorization for ...